Morphine-induced hyperalgesia impacts small extracellular vesicle microRNA composition and function.

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Opioid analgesics like morphine are widely used for pain management.
• Prolonged opioid use can paradoxically increase pain sensitivity, a phenomenon known as opioid-induced hyperalgesia.
• The molecular mechanisms driving opioid-induced hyperalgesia remain incompletely understood.

Purpose of the Study:

• To investigate molecular changes in serum small extracellular vesicles (sEVs) following morphine treatment that induces hyperalgesia.
• To identify specific microRNAs (miRNAs) within sEVs that may regulate pain pathways.
• To assess the therapeutic potential of morphine-altered sEVs in modulating pain sensitivity.

Main Methods:

• Induction of hyperalgesia in mice using a morphine treatment paradigm.
• Analysis of miRNA composition in serum-derived sEVs from treated and control mice.
• Bioinformatic prediction and experimental validation of miRNA targets, including CREB (cyclic AMP response element binding protein).
• Administration of sEVs to naïve recipient mice to assess their impact on nociceptive behavior.

Main Results:

• Significant differential expression of 18 miRNAs was observed in sEVs from morphine-treated mice.
• miR-155 and miR-10a within sEVs were confirmed to bind and repress Creb mRNA.
• Intrathecal injection of sEVs did not alter basal pain thresholds but accelerated the resolution of inflammatory hypersensitivity in recipient mice.
• Administration of these sEVs did not affect other behaviors like conditioned place preference or locomotor sensitization.

Conclusions:

• Morphine treatment alters the miRNA cargo of serum sEVs.
• These sEVs, particularly those modulating CREB expression, show potential for treating pain hypersensitivity.
• Serum sEVs represent a promising non-opioid therapeutic strategy for pain management and offer insights into opioid-induced hyperalgesia pathophysiology.